Advanced Search

Oncology & Hematology Coding Alert

Code Revisions:

J7178 Brings Permanent Human Fibrinogen Option in 2013

Published on Tue Dec 18, 2012

Stay alert to units and admin method for these updated non-chemotherapy HCPCS codes. The changes to HCPCS 2013, effective January 1, answer the call for codes that describe newly available drugs, new options for administration, and a need for consistency in calculating units. Here are four areas to watch. J1569 Is Now OK for Sub-Q Admin Immune globulin codes will see some minor revisions for 2013. J1561: The first change is the deletion of the outdated brand name Gamunex from J1561: 2012: J1561, Injection, immune globulin, (Gamunex/Gamunex-C/Gammaked), non-lyophilized (e.g. liquid), 500 mg 2013: J1561, Injection, immune globulin, (Gamunex-C/Gammaked), non-lyophilized (e.g., liquid), 500 mg. J1569: The second change removes the term intravenous from Gammagard Liquid code J1569: 2012: J1569, Injection, immune globulin, (Gammagard Liquid), intravenous, non-lyophilized, (e.g., liquid), 500 mg 2013: J1569, Injection, immune globulin, (Gammagard Liquid), non-lyophilized, (e.g., liquid), 500 mg. The revision ensures that J1569 use is not limited [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in Revenue Cycle Insider
  • 6 annual AAPC-approved CEUs
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more

Other Articles in this issue of

Oncology & Hematology Coding Alert

View All